NEW YORK – Parse Biosciences said Wednesday that it has inked a distribution agreement with Prisma Biotech to make its single-cell products available in Taiwan and elsewhere in Asia-Pacific.
Financial terms of the deal were not disclosed.
Prisma will distribute Parse’s single-cell portfolio, including reagent kits and data analysis solutions, to customers in Taiwan and other countries in the region.
"Our partnership with Parse will bring single-cell sequencing to a wide range of researchers in Taiwan and the larger Asia-Pacific region, and we’re excited to support scientific discoveries the tools enable," Prisma CEO Kevin Tseng said in a statement.
Prisma is the latest in Parse’s growing list of global distributors. The Seattle-based company previously inked similar deals covering South America, India, Israel, Oceania, and South Korea.